Modified aerolysin and methods of use for treating lung cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 20, 2006
app pub date -
Mar 2, 2004
filing date -
Mar 3, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Disclosed herein are peptides that include aerolysin (or an aerolysin homolog) linked to an agent that specifically binds to a lung cancer cell, as well as nucleic acid sequences that encode such peptides. Methods of using such peptides and nucleic acid sequences to treat lung cancer are also disclosed.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully